North Star Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.32M Buy
10,951
+39
+0.4% +$4.5K 0.06% 170
2025
Q4
$1.15M Sell
10,912
-930
-8% -$87.3K 0.05% 182
2025
Q3
$994K Sell
11,842
-154
-1% -$12.7K 0.04% 191
2025
Q2
$950K Buy
11,996
+192
+2% +$15.3K 0.04% 184
2025
Q1
$1.06M Buy
11,804
+426
+4% +$39.8K 0.05% 167
2024
Q4
$1.13M Buy
11,378
+270
+2% +$27.8K 0.05% 166
2024
Q3
$1.26M Sell
11,108
-46
-0.4% -$5.46K 0.06% 163
2024
Q2
$1.38M Sell
11,154
-144
-1% -$18.5K 0.07% 149
2024
Q1
$1.49M Sell
11,298
-36
-0.3% -$4.44K 0.07% 149
2023
Q4
$1.24M Sell
11,334
-1,260
-10% -$131K 0.06% 155
2023
Q3
$1.3M Buy
12,594
+11
+0.1% +$1.19K 0.07% 150
2023
Q2
$1.45M Sell
12,583
-175
-1% -$19.9K 0.08% 147
2023
Q1
$1.36M Sell
12,758
-71
-0.6% -$7.67K 0.08% 144
2022
Q4
$1.42M Buy
12,829
+1,620
+14% +$166K 0.09% 140
2022
Q3
$965K Buy
11,209
+57
+0.5% +$5.09K 0.07% 154
2022
Q2
$1.02M Sell
11,152
-319
-3% -$28.3K 0.07% 153
2022
Q1
$941K Sell
11,471
-12
-0.1% -$946 0.05% 167
2021
Q4
$880K Buy
11,483
+65
+0.6% +$5.18K 0.04% 171
2021
Q3
$858K Buy
11,418
+155
+1% +$11.8K 0.05% 171
2021
Q2
$876K Sell
11,263
-572
-5% -$42.5K 0.05% 167
2021
Q1
$871K Sell
11,835
-120
-1% -$8.85K 0.05% 162
2020
Q4
$933K Sell
11,955
-420
-3% -$32.1K 0.06% 149
2020
Q3
$979K Sell
12,375
-96
-0.8% -$7.52K 0.07% 133
2020
Q2
$920K Buy
12,471
+1,749
+16% +$132K 0.07% 136
2020
Q1
$787K Sell
10,722
-501
-4% -$39.4K 0.08% 134
2019
Q4
$974K Sell
11,223
-802
-7% -$65.9K 0.07% 147
2019
Q3
$966K Sell
12,025
-209
-2% -$16.8K 0.08% 146
2019
Q2
$979K Buy
12,234
+504
+4% +$38.6K 0.08% 150
2019
Q1
$931K Buy
11,730
+26
+0.2% +$1.95K 0.08% 152
2018
Q4
$853K Sell
11,704
-338
-3% -$23.9K 0.08% 149
2018
Q3
$815K Sell
12,042
-288
-2% -$18.3K 0.07% 163
2018
Q2
$714K Sell
12,330
-450
-4% -$25.4K 0.06% 169
2018
Q1
$664K Buy
12,780
+136
+1% +$7.34K 0.06% 173
2017
Q4
$679K Sell
12,644
-7,177
-36% -$398K 0.06% 174
2017
Q3
$1.21M Sell
19,821
-220
-1% -$13.3K 0.12% 138
2017
Q2
$1.23M Sell
20,041
-28
-0.1% -$1.7K 0.12% 133
2017
Q1
$1.22M Hold
20,069
0.13% 136
2016
Q4
$1.13M Sell
20,069
-210
-1% -$12.3K 0.12% 137
2016
Q3
$1.21M Hold
20,279
0.14% 129
2016
Q2
$1.11M Hold
20,279
0.13% 132
2016
Q1
$1.02M Sell
20,279
-96
-0.5% -$4.7K 0.12% 138
2015
Q4
$1.03M Sell
20,375
-917
-4% -$46.2K 0.12% 145
2015
Q3
$1M Hold
21,292
0.12% 144
2015
Q2
$1.16M Hold
21,292
0.13% 143
2015
Q1
$1.17M Sell
21,292
-105
-0.5% -$5.95K 0.13% 142
2014
Q4
$1.16M Buy
21,397
+161
+0.8% +$8.97K 0.13% 140
2014
Q3
$1.2M Hold
21,236
0.14% 137
2014
Q2
$1.17M Sell
21,236
-314
-1% -$17.1K 0.14% 138
2014
Q1
$1.17M Hold
21,550
0.14% 137
2013
Q4
$1.03M Sell
21,550
-160
-0.7% -$7.31K 0.12% 143
2013
Q3
$986K Sell
21,710
-472
-2% -$21.6K 0.13% 141
2013
Q2
$983K Buy
+22,182
New +$991K 0.14% 135

Other funds holding MRK

North Star Asset Management's MRK Position: Q1 2026 in Review

North Star Asset Management increased its Merck (MRK) stake by 0.36% in Q1 2026, buying an estimated $4.5K and bringing the position to 10,951 shares worth $1.32M. The position accounts for 0.06% of the portfolio, ranked #170.

North Star Asset Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.49M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • North Star Asset Management held 10,951 shares of Merck worth $1.32M as of Q1 2026.
  • North Star Asset Management bought 39 Merck shares in Q1 2026, an estimated $4.5K.
  • Merck made up 0.06% of North Star Asset Management's portfolio in Q1 2026, its #170 holding.
  • North Star Asset Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • North Star Asset Management's Merck position peaked at $1.49M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on North Star Asset Management's 13F filing for Q1 2026, filed 6 May 2026.